Ronald G Racho1,2, Murli Krishna3, Susan G Coe4, Colleen S Thomas5, Julia E Crook5, Nancy N Diehl5, Michael B Wallace6. 1. Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA. 2. Department of Gastroenterology, University of Kentucky College of Medicine, Lexington, KY, USA. 3. Department of Pathology, Mayo Clinic, Jacksonville, FL, USA. 4. Atlanta Gastroenterology Associates, Snellville, GA, USA. 5. Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville, FL, USA. 6. Division of Gastroenterology, Mayo Clinic, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. wallace.michael@mayo.edu.
Abstract
BACKGROUND: Sessile serrated adenomas/polyps (SSA/P) are an under-recognized disease with a unique malignant pathway. Improved endoscopic recognition and pathological interpretation is needed. AIMS: To determine whether an educational intervention that improved adenoma detection rate (ADR) could improve SSA/P detection rate after reclassification of previously termed "hyperplastic" polyps. METHODS: We reanalyzed data from a prospective randomized trial of an educational intervention aimed at increasing ADR. All hyperplastic polyps ≥6 mm reported in a previously published study were rereviewed and reclassified using standardized criteria for serrated lesions. Detection rates of sessile serrated adenomas/polyps and other clinically relevant serrated polyps were calculated in the baseline and post-training phases of the original study. RESULTS: Of 263 available for rereview, 33 (12.5%) were reclassified as SSA/P (N = 32) or traditional serrated adenoma (TSA) (N = 1). Reclassification was more common in the right colon (18 vs. 8%, p = 0.02). Baseline SSA/P detection rate was 0.7% in the untrained group and 1.3% in the trained group. Post-training, the SSA/P detection rate increased to 2.1 and 1.5%, respectively. The clinically relevant serrated polyp detection rate at baseline was 14.2% in the untrained group and 11.3% in the trained group. After the educational intervention, the clinically relevant serrated polyp detection rates increased to 16.5 and 14.8% in the untrained and trained groups, respectively. The estimated odds of an endoscopist detecting either a SSA/P or other clinically relevant serrated polyp during colonoscopy increased by only 3% with the educational intervention (OR 1.03, 95% CI 0.61-1.74, p = 0.91). CONCLUSIONS: Pathological re-interpretation of larger serrated polyps resulted in the reclassification of 12.5% of lesions. Quality improvement methods focused on adenoma detection did not impact SSA/P detection, and thus specific methods for serrated polyp detection are needed.
RCT Entities:
BACKGROUND: Sessile serrated adenomas/polyps (SSA/P) are an under-recognized disease with a unique malignant pathway. Improved endoscopic recognition and pathological interpretation is needed. AIMS: To determine whether an educational intervention that improved adenoma detection rate (ADR) could improve SSA/P detection rate after reclassification of previously termed "hyperplastic" polyps. METHODS: We reanalyzed data from a prospective randomized trial of an educational intervention aimed at increasing ADR. All hyperplastic polyps ≥6 mm reported in a previously published study were rereviewed and reclassified using standardized criteria for serrated lesions. Detection rates of sessile serrated adenomas/polyps and other clinically relevant serrated polyps were calculated in the baseline and post-training phases of the original study. RESULTS: Of 263 available for rereview, 33 (12.5%) were reclassified as SSA/P (N = 32) or traditional serrated adenoma (TSA) (N = 1). Reclassification was more common in the right colon (18 vs. 8%, p = 0.02). Baseline SSA/P detection rate was 0.7% in the untrained group and 1.3% in the trained group. Post-training, the SSA/P detection rate increased to 2.1 and 1.5%, respectively. The clinically relevant serrated polyp detection rate at baseline was 14.2% in the untrained group and 11.3% in the trained group. After the educational intervention, the clinically relevant serrated polyp detection rates increased to 16.5 and 14.8% in the untrained and trained groups, respectively. The estimated odds of an endoscopist detecting either a SSA/P or other clinically relevant serrated polyp during colonoscopy increased by only 3% with the educational intervention (OR 1.03, 95% CI 0.61-1.74, p = 0.91). CONCLUSIONS: Pathological re-interpretation of larger serrated polyps resulted in the reclassification of 12.5% of lesions. Quality improvement methods focused on adenoma detection did not impact SSA/P detection, and thus specific methods for serrated polyp detection are needed.
Entities:
Keywords:
Adenoma detection rate; Colonoscopy; Colorectal cancer prevention; Serrated polyps
Authors: Kyoung-Mee Kim; Eui Jin Lee; Sangyun Ha; So Young Kang; Kee-Taek Jang; Cheol Keun Park; Jin Yong Kim; Young Ho Kim; Dong Kyung Chang; Robert Daniel Odze Journal: Am J Surg Pathol Date: 2011-09 Impact factor: 6.394
Authors: Joep E G IJspeert; Sascha C van Doorn; Ymkje M van der Brug; Barbara A J Bastiaansen; Paul Fockens; Evelien Dekker Journal: Gastrointest Endosc Date: 2015-04-29 Impact factor: 9.427
Authors: Douglas K Rex; Dennis J Ahnen; John A Baron; Kenneth P Batts; Carol A Burke; Randall W Burt; John R Goldblum; José G Guillem; Charles J Kahi; Matthew F Kalady; Michael J O'Brien; Robert D Odze; Shuji Ogino; Susan Parry; Dale C Snover; Emina Emilia Torlakovic; Paul E Wise; Joanne Young; James Church Journal: Am J Gastroenterol Date: 2012-06-19 Impact factor: 10.864
Authors: Charles J Kahi; David G Hewett; Dustin Lee Norton; George J Eckert; Douglas K Rex Journal: Clin Gastroenterol Hepatol Date: 2010-10-01 Impact factor: 11.382
Authors: Joseph C Anderson; Lynn F Butterly; Martha Goodrich; Christina M Robinson; Julia E Weiss Journal: Clin Gastroenterol Hepatol Date: 2013-05-06 Impact factor: 11.382
Authors: Rebecca A Gourevitch; Sherri Rose; Seth D Crockett; Michele Morris; David S Carrell; Julia B Greer; Reetesh K Pai; Robert E Schoen; Ateev Mehrotra Journal: Am J Gastroenterol Date: 2018-01-30 Impact factor: 10.864
Authors: Arne G C Bleijenberg; Monique E van Leerdam; Marloes Bargeman; Jan Jacob Koornstra; Yasmijn J van Herwaarden; Manon Cw Spaander; Silvia Sanduleanu; Barbara A J Bastiaansen; Erik J Schoon; Niels van Lelyveld; Evelien Dekker; Joep E G IJspeert Journal: Gut Date: 2020-03-05 Impact factor: 23.059